What is the standard of care for colon cancer prevention in Crohn disease?

Updated: Jul 26, 2019
  • Author: Leyla J Ghazi, MD; Chief Editor: Praveen K Roy, MD, AGAF  more...
  • Print
Answer

Overall, with the advent of new technology (eg, chromoendoscopy) and the accumulation of evidence for the use of chemoprophylactic agents (eg, 5-aminosalicylic acid [5-ASA] and low-dose ursodiol), it appears that there may be a reduction in the risk for colorectal cancer in Crohn disease. At present, surveillance colonoscopy every 1-3 years remains the standard of care.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!